Cargando…
Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction
OBJECTIVE: The occurrence of cardiovascular adverse events in the first year after ST-acute myocardial infarction (STEMI) remains high; therefore, identification of patients with poor prognosis is essential for early intervention. This study aimed to evaluate the prognostic value of metabolomics-bas...
Autores principales: | Zhang, Xiaolin, Cai, Yi, Su, Xu, Jing, Quanmin, Liu, Haiwei, Na, Kun, Qiu, Miaohan, Tian, Xiaoxiang, Liu, Dan, Wu, Tianxiao, Yan, Chenghui, Han, Yaling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667794/ https://www.ncbi.nlm.nih.gov/pubmed/36405744 http://dx.doi.org/10.3389/fimmu.2022.950441 |
Ejemplares similares
-
Corrigendum: Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction
por: Zhang, Xiaolin, et al.
Publicado: (2023) -
Bioinformatics analyses of potentially common pathogenic networks for primary Sjögren’s syndrome complicated with acute myocardial infarction
por: Hou, Qingbin, et al.
Publicado: (2023) -
Role of Neutrophil-Derived S100B in Acute Myocardial Infarction Patients From the Han Chinese Population
por: Cheng, Minghui, et al.
Publicado: (2021) -
Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial Infarction
por: Zhang, Xiaolin, et al.
Publicado: (2021) -
Corrigendum: Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial Infarction
por: Zhang, Xiaolin, et al.
Publicado: (2022)